Other important questions remain around Nutlin-3 activity in prostate cancer, including the mechanism of AR downregulation, the relative contribution of cell cycle arrest versus apoptosis, and the impact upon AR-driven pro-survival genes. The gene discussed is AR; the disease is prostate carcinoma.